Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction-论文-万方医学网

首页> > Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction

Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction

导出原文传递

翻译打印收藏纠错

第一作者： Bunsawat, Kanokwan

作者： Bunsawat, Kanokwan ^[1] ; Ratchford, Stephen M. ^[2] ; Alpenglow, Jeremy K. ^[3] ; Park, Soung Hun ^[4] ; Jarrett, Catherine L. ; Stehlik, Josef ; Smith, Adam S. ; Richardson, Russell S. ; Wray, D. Walter

作者单位： Univ Utah, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA ^[1] Univ Utah, Dept Nutr & Integrat Physiol, Salt Lake City, UT USA ^[2] Univ Utah, Dept Internal Med, Div Cardiovasc Med, Salt Lake City, UT 84112 USA ^[3] Univ Utah, Dept Pharm Serv, Salt Lake City, UT USA ^[4]

关键词 Entresto flow-mediated dilation heart failure reactive hyperemia

发布时间 2022-09-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction

相似文献

同项目论文

相关期刊

检索历史 清除

Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction

相似文献

同项目论文

相关期刊

检索历史清除